• [Review]
  • Design and Application of Drug Carrier Based on Drug Delivery System for Effective Disease Therapy

  • Yoo-Sung Choi and Gyeong-Won Jeong† 

  • Department of Bioenvironmental & Chemical Engineering, Chosun College of Science and Technology, Gwangju 61453, Korea

  • 효과적인 질병 치료를 위한 약물전달시스템 기반 약물 전달체 설계 및 응용

  • 최유성 · 정경원† 

  • 조선이공대학교 생명환경화공과

  • Reproduction, stored in a retrieval system, or transmitted in any form of any part of this publication is permitted only by written permission from the Polymer Society of Korea.

References
  • 1. Langer, R.; Folkman, J. Polymers for the Sustained Release of Proteins and Other Macromolecules. Nature 1976, 263, 797-800.
  •  
  • 2. Langer, R. Drug Delivery and Targeting. Nature 1998, 392, 5-10.
  •  
  • 3. Kataoka, K.; Harada, A.; Nagasaki, Y. Block Copolymer Micelles for Drug Delivery: Design, Characterization and Biological Significance. Adv. Drug Deliv. Rev. 2001, 47, 113-131.
  •  
  • 4. Duncan, R. The Dawning Era of Polymer Therapeutics. Nat. Rev. Drug Discov. 2003, 2, 347-360.
  •  
  • 5. Bae, Y.; Kataoka, K. Intelligent Polymeric Micelles from Functional Poly(ethylene glycol)-Poly(amino acid) Block Copolymers for Anticancer Drug Delivery. Adv. Drug Deliv. Rev. 2009, 61, 768-784.
  •  
  • 6. Torchilin, V. P. Multifunctional, Stimuli-Sensitive Nanoparticulate Systems for Drug Delivery. Nat. Rev. Drug Discov. 2014, 13, 813-827.
  •  
  • 7. Farokhzad, O. C.; Langer, R. Impact of Nanotechnology on Drug Delivery. ACS Nano. 2009, 3, 16-20.
  •  
  • 8. Peer, D.; Karp, J. M.; Hong, S.; Farokhzad, O. C.; Margalit, R.; Langer, R. Nanocarriers as an Emerging Platform for Cancer Therapy. Nat. Nanotechnol. 2007, 2, 751-760.
  •  
  • 9. Allen, T. M.; Cullis, P. R. Liposomal Drug Delivery Systems: From Concept to Clinical Applications. Adv. Drug Deliv. Rev. 2013, 65, 36-48.
  •  
  • 10. Park, K. Controlled Drug Delivery Systems: Past Forward and Future Back. J. Control. Release 2014, 190, 3-8.
  •  
  • 11. Yang, S. Y. Pharmacophore Modeling and Applications in Drug Discovery: Challenges and Recent Advances. Drug Discov. Today 2010, 15, 444-450.
  •  
  • 12. Li, J.; Mooney, D. J. Designing Hydrogels for Controlled Drug Delivery. Nat. Rev. Mater. 2016, 1, 16071.
  •  
  • 13. Ulbrich, K.; Holá, K. Targeted Drug Delivery with Polymers and Magnetic Nanoparticles: Covalent and Noncovalent Approaches, Release Control, and Clinical Studies. Chem. Rev. 2016, 116, 5338-5431.
  •  
  • 14. Owens, D. E.; Peppas, N. A. Opsonization, Biodistribution, and Pharmacokinetics of Polymeric Nanoparticles. Int. J. Pharm. 2006, 307, 93-102.
  •  
  • 15. Lee, H.; Mok, H.; Lee, S.; Oh, Y. K.; Park, T. G. Target-Specific Intracellular Delivery of siRNA Using Degradable Hyaluronic Acid Nanogels. J. Control. Release 2007, 119, 245-252.
  •  
  • 16. Siepmann, J.; Peppas, N. A. Higuchi Equation: Derivation, Applications, Use and Misuse. Int. J. Pharm. 2011, 418, 6-12.
  •  
  • 17. Peppas, N. A.; Langer, R. New Challenges in Biomaterials. Science 1994, 263, 1715-1720.
  •  
  • 18. Suman, J. D.; Laube, B. L.; Dalby, R. Comparison of Nasal Deposition and Clearance of Aerosol Generated by a Nebulizer and An Aqueous Spray Pump. Pharm. Res. 1999, 16, 1648-1652.
  •  
  • 19. Kim, J. A.; Choi, J. H.; Kim, M.; Rhee, W. J.; Son, B.; Jung, H. K.; Park, T. H. High-throughput Generation of Spheroids Using Magnetic Nanoparticles for Three-dimensional Cell Culture. Biomaterials 2013, 34, 8555-8563.
  •  
  • 20. Jeong, B.; Kim, S. W.; Bae, Y. H. Thermosensitive Sol-Gel Reversible Hydrogels. Adv. Drug Deliv. Rev. 2002, 54, 37-51.
  •  
  • 21. Lee, S. H.; Shin, H. Matrices and Scaffolds for Delivery of Bioactive Molecules in Bone and Cartilage Tissue Engineering. Adv. Drug Deliv. Rev. 2007, 59, 339-359.
  •  
  • 22. Kim, K. S.; Park, W. R.; Hu, J.; Bae, Y. H.; Na, K. A Cancer-recognizable MRI Contrast Agents Using pH-responsive Polymeric Micelle. Biomaterials 2014, 35, 337-343.
  •  
  • 23. Shahriari, M.; Zahiri, M.; Abnous, K.; Taghdisi, S. M.; Ramezani, M.; Alibolandi, M. Enzyme Responsive Drug Delivery Systems in Cancer Treatment. J. Control. Release 2019, 308, 172-189.
  •  
  • 24. Mura, S.; Nicolas, J.; Couvreur, P. Stimuli-Responsive Nanocarriers for Drug Delivery. Nat. Mater. 2013, 12, 991-1003.
  •  
  • 25. Li, Y.; Maciel, D.; Rodrigues, J.; Shi, X.; Tomás, H. Biodegradable Polymer Nanogels for Drug/Nucleic Acid Delivery. Chem. Rev. 2015, 115, 8564-8608.
  •  
  • 26. Wang, A. Z.; Langer, R.; Farokhzad, O. C. Nanoparticle Delivery of Cancer Drugs. Annu. Rev. Med. 2012, 63, 185-198.
  •  
  • 27. Maeda, H.; Wu, J.; Sawa, T.; Matsumura, Y.; Hori, K. Tumor Vascular Permeability and the EPR Effect in Macromolecular Therapeutics: A Review. J. Control. Release 2000, 65, 271-284.
  •  
  • 28. Shi, J.; Kantoff, P. W.; Wooster, R.; Farokhzad, O. C. Cancer Nanomedicine: Progress, Challenges and Opportunities. Nat. Rev. Cancer 2017, 17, 20-37.
  •  
  • 29. Nangare, S.; Joshi, V.; Magdum, S.; Patil, R.; Patil, V. Colloidal Drug Delivery Systems for Infectious Diseases of Skin. Curr. Opin. Pharmacol. 2025, 83, 102536.
  •  
  • 30. Kamaly, N.; Yameen, B.; Wu, J.; Farokhzad, O. C. Degradable Controlled-Release Polymers and Polymeric Nanoparticles: Mechanisms of Controlling Drug Release. Chem. Rev. 2016, 116, 2602-2663.
  •  
  • 31. Hrkach, J.; Hoff, D. V.; Ali, M. M.; Andrianova, E.; Auer, J.; Campbell, T.; Witt, D. D.; Figa, M.; Figueiredo, M.; Horhota, A.; Low, S.; McDonnell, K.; Peeke, E.; Retnarajan, B.; Sabnis, A.; Schnipper, E.; Song, J. J.; Song, Y. H.; Summa, J.; Tompsett, D.; Troiano, G.; Hoven, T. V. G.; Wright, J.; LoRusso, P.; Kantoff, P. W.; Bander, N. H.; Sweeney, C.; Farokhzad, O. C.; Langer, R.; Zale, S. Preclinical Development and Clinical Translation of a PSMA-Targeted Docetaxel Nanoparticle with a Differentiated Pharmacological Profile. Sci. Transl. Med. 2012, 4, 128ra39.
  •  
  • 32. Barenholz, Y. Doxil®-The First FDA-Approved Nano-Drug: Lessons Learned. J. Control. Release 2012, 160, 117-134.
  •  
  • 33. Xie, J.; Lee, S.; Chen, X. Nanoparticle-Based Theranostic Agents. Adv. Drug Deliv. Rev. 2010, 62, 1064-1079.
  •  
  • 34. Na, K.; Bae, Y. H. pH-Sensitivity and pH-Dependent Interior Structural Change of Self-Assembled Hydrogel Nanoparticles of Pullulan Acetate/Oligo-sulfonamide Conjugate. J. Control. Release 2004, 97, 513-525.
  •  
  • 35. Yazdan, M.; Naghib, S.M.; Mozafari, M.R. Polymeric Micelle-Based Nanogels as Emerging Drug Delivery Systems in Breast Cancer Treatment: Promises and Challenges. Biomaterials 2024, 25, 649-669.
  •  
  • 36. Huang, X.; Brazel, C. S. On the Importance and Mechanisms of Burst Release in Matrix-Controlled Drug Delivery Systems. J. Control. Release 2001, 73, 121-136.
  •  
  • 37. Peppas, N. A.; Bures, P.; Leobandung, W.; Ichikawa, H. Hydrogels in Pharmaceutical Formulations. Eur. J. Pharm. Biopharm. 2000, 50, 27-46.
  •  
  • 38. Park, S. Y.; Kang, J. H.; Kim, H. S.; Hwang, J. Y.; Shin, U. S. Electrical and Thermal Stimulus-responsive Nanocarbon-based 3D Hydrogel Sponge for Switchable Drug Delivery. Nanoscale 2022, 14, 2367-2382.
  •  
  • 39. Caló, E.; Khutoryanskiy, V. V. Biomedical Applications of Hydrogels: A Review of Patents and Commercial Products. Eur. Polym. J. 2015, 65, 252-267.
  •  
  • 40. Ahmed, E. M. Hydrogel: Preparation, Characterization, and Applications: A Review. J. Adv. Res. 2015, 6, 105-121.
  •  
  • 41. Cheng, J.; Teply, B. A.; Sherifi, I.; Sung, J.; Luther, G.; Gu, F. X.; Levy-Nissenbaum, E.; Radovic-Moreno, A. F.; Langer, R.; Farokhzad, O. C. Formulation of Functionalized PLGA-PEG Nanoparticles for In Vivo Targeted Drug Delivery. Biomaterials 2007, 28, 869-876.
  •  
  • 42. Grossen, P.; Witzigmann, D.; Sieber, S.; Huwyler, J. PEG-PCL-Based Nanomedicines: A Biodegradable Drug Delivery System and Its Application. J. Control. Release 2017, 260, 46-60.
  •  
  • 43. Yamada, S.; Sasaki, E.; Ohno, H.; Hanaoka, K. Heat-Guided Drug Delivery via Thermally Induced Crosslinking of Polymeric Micelles. Commun. Chem. 2024, 7, 287.
  •  
  • 44. Huo, M.; Yuan, J.; Tao, L.; Wei, Y. Redox-Responsive Polymers for Drug Delivery: From Molecular Design to Applications. Polym. Chem. 2014, 5, 1519-1528.
  •  
  • 45. Mazzotta, E.; De Santo, M.; Lombardo, D.; Leggio, A.; Pasqua, L. Mesoporous Silicas in Materials Engineering: Nanodevices for Bionanotechnologies. Mater. Today Bio. 2022, 17, 100472.
  •  
  • 46. Danhier, F.; Feron, O.; Préat, V. To Exploit the Tumor Microenvironment: Passive and Active Tumor Targeting of Nanocarriers for Anti-Cancer Drug Delivery. J. Control. Release 2010, 148, 135-146.
  •  
  • 47. Choi, Y. S.; Jeong, G. W. Utilization and Application of Biopolymer in Biomedical Science Field. J. Chitin Chitosan 2024, 29, 229-235.
  •  
  • 48. Liu, L.; Wu, D.; Tu, H.; Cao, M.; Li, M.; Peng, L.; Yang, J. Applications of Hydrogels in Drug Delivery for Oral and Maxillofacial Diseases. Gels 2023, 9, 146.
  •  
  • Polymer(Korea) 폴리머
  • Frequency : Bimonthly(odd)
    ISSN 2234-8077(Online)
    Abbr. Polym. Korea
  • 2024 Impact Factor : 0.6
  • Indexed in SCIE

This Article

  • 2026; 50(3): 365-373

    Published online May 25, 2026

  • 10.7317/pk.2026.50.3.365
  • Received on Nov 18, 2025
  • Revised on Feb 2, 2026
  • Accepted on Feb 20, 2026

Correspondence to

  • Gyeong-Won Jeong

  • Department of Bioenvironmental & Chemical Engineering, Chosun College of Science and Technology, Gwangju 61453, Korea

  • E-mail: gwjeong@cst.ac.kr